-
Scientists from St. Jude Children’s Research Hospital listed among most cited globally
11/19/2024
Meet the St. Jude scientists named to the 2024 list of Highly Cited Researchers produced by Clarivate, to celebrate the global influence of their discoveries.
-
St. Jude researchers identify unexpected genetic link between skin disorder and inner ear
11/18/2024
Discover St. Jude research showing how the ABC transporter links inner ear development with hearing impairment in dyschromatosis universalis hereditaria.
-
Glutamine metabolic switch is key to red blood cell development and disease
11/14/2024
See how a switch from glutamine catabolism to glutamine production is a vital step in blood cell development linking the process to sickle cell disease and β-thalassemia
-
Tumor suppressor forms gel-like assemblies to sacrifice cancer cells
11/11/2024
See how the tumor suppressor p14ARF undergoes phase separation with nucleophosmin to form condensates which arrest ribosome formation to kill cancer cells.
-
Mitchell Weiss of St. Jude Children’s Research Hospital elected to the National Academy of Medicine
10/23/2024
Leading expert in catastrophic blood disorders becomes the seventh St. Jude faculty member tapped for this honor
-
Nutrients and organelle signaling shape tissue immunity
10/14/2024
Discover research by Hongbo Chi, PhD, that uncovers the interplay between organelles, nutrient-dependent signaling pathways and tissue immunity.
-
Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy
10/10/2024
Explore how disruptions in ASXL1 were correlated with better patient responses to immune checkpoint inhibition and long-term tumor control in model systems.
-
St. Jude ranks in top 10 of U.S. News Best Children's Hospitals for Cancer
10/08/2024
US News & World Report has recognized St. Jude Children's Research Hospital as one of the top 10 pediatric cancer hospitals for the 17th straight year.
-
St. Jude names M. Madan Babu, PhD, senior vice president and chief data scientist
10/01/2024
M. Madan Babu, PhD, will lead new $195 million data science enterprise for biologic discovery to advance pediatric medicine.
-
Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows its promise for gene editing
10/01/2024
See how structures of Fanzor2, a relation of the transposon family TnpB, show how the protein can be used in genome engineering technology like CRISPR-Cas9.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.